Krx Aesthetics Pd-13 Therapy Spray
NDC Package 84755-0010-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Krx Aesthetics Pd-13 Therapy sprays is krx Aesthetics PD-13 Therapy, which includes 13% of Methyl Aminolevulinate HCI, is developed to maximize the client’s satisfaction for PDT(Photo Dynamic Therapy). This formulation utilizes a spray delivery system. Marketed by Krx Resources Sdn. Bhd., this product is identified by NDC 84755-0010.

Identification & Billing

NDC Package Code
84755-0010-1
Package Description
15 mL in 1 PACKAGE
Product Code
84755-0010
11-Digit Billing Format
84755001001

Clinical Specifications

Proprietary Name
Krx Aesthetics Pd-13 Therapy
Non-Proprietary Name
Krx Aesthetics Pd-13 Therapy
Substance Name
Methyl Aminolevulinate Hydrochloride
Dosage Form
Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
METHYL AMINOLEVULINATE HYDROCHLORIDE 1.95 mg/15mL
Pharmacologic Class
Usage Information
Krx Aesthetics PD-13 Therapy, which includes 13% of Methyl Aminolevulinate HCI, is developed to maximize the client’s satisfaction for PDT(Photo Dynamic Therapy).

Regulatory & Marketing

Labeler Name
Krx Resources Sdn. Bhd.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
01-01-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84755-0010-1 identifies a specific commercial package of 15 ml in 1 package of Krx Aesthetics Pd-13 Therapy, a human over the counter drug labeled by Krx Resources Sdn. Bhd.. This spray is formulated for topical use and contains methyl aminolevulinate hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Krx Resources Sdn. Bhd. on January 01, 2026. The current certification is valid through December 31, 2027.

How is this Krx Resources Sdn. Bhd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84755001001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
84755-0010-1
11-Digit CMS (5-4-2)
84755-0010-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.